Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009
- PMID: 23369034
- PMCID: PMC3585510
- DOI: 10.1186/1471-2334-13-57
Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009
Abstract
Background: Asthma was the most common co-morbidity among patients hospitalized with pandemic influenza A(H1N1)pdm09 [pH1N1] infection. The objective was to compare characteristics of hospitalized pH1N1 patients with and without asthma and assess factors associated with severity among asthma patients.
Methods: Patient data were derived from two 2009 pandemic case-series of U.S. pH1N1 hospitalizations. A case was defined as a person ≥ 2 years old hospitalized with laboratory-confirmed pH1N1. Asthma status was determined through chart review.
Results: Among 473 cases, 29% had asthma. Persons with asthma were more likely to be 2-17 years old (39% vs. 30%, p = 0.04) and black (29% vs. 18%, p < 0.01), and have chronic obstructive pulmonary disease (13% vs. 9%, p = 0.04) but less likely to have pneumonia (37% vs. 47%, p = 0.05), need mechanical ventilation (13% vs. 23%, p = 0.02), and die (4% vs. 10%, p = 0.04) than those without asthma. Among patients with asthma, those admitted to an intensive care unit (ICU) or who died (n = 38) compared with survivors not admitted to an ICU (n = 99) were more likely to have pneumonia on admission (60% vs. 27%, p < 0.01) or acute respiratory distress syndrome (24% vs. 0%, p < 0.01) and less likely to receive influenza antiviral agents ≤ 2 days of admission (73% vs. 92%, p = 0.02).
Conclusions: The majority of persons with asthma had an uncomplicated course; however, severe disease, including ICU admission and death, occurred in asthma patients who presented with pneumonia. Influenza antiviral agents should be started early in hospitalized patients with suspected influenza, including those with asthma.
References
-
- World Health Organization Influenza (Seasonal) Fact sheet No 211, April 2009. [ http://www.who.int/mediacentre/factsheets/fs211/en/]
-
- Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. 2007. (World Health Organization). [ http://www.who.int/gard/publications/GARD%20Book%202007.pdf]
-
- Bateman ED, Boulet LP, Cruz AA, Fitzgerald M, Haahtela T, Levy ML, O’Byrne P, Ohta K, Paggiaro P, Pedersen SE, Soto-Quiroz M, Wong GW, for the Global Initiative for Asthma Executive Committee. Global Strategy for Asthma Management and Prevention 2011 (update) [ http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asth...]
-
- Zahran HS, Bailey C, Garbe P. Vital Signs: Asthma Prevalence, Disease Characteristics, and Self-Management Education — United States, 2001–2009. MMWR. 2011;60:1–7. - PubMed
-
- Dawood FS, Fiore A, Kamimoto L, Bramley AM, Reingold A, Gershman K, Meck J, Hadler J, Arnold KE, Ryan P, Lynfield R, Morin C, Mueller M, Baumbach J, Zansky S, Bennett NM, Thomas A, Schaffner W, Kirschke D, Finelli L. Burden of Seasonal Influenza Hospitalization in Children, United States, 2003 to 2008. J Pediatr. 2010;157(5):808–814. doi: 10.1016/j.jpeds.2010.05.012. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical